Head of Expansion at AIOS — Remote, $200-$400k/yr + .15% - 0.5% equity

AIOS (YC W20/S21)

10d•$200,000 - $400,000•Remote

About The Position

AIOS is building the world’s first full-stack AI doctor. We’re at $350M ARR, growing from $10M/yr 12 months ago, making us the world’s fastest growing AI doctor. We faithfully serve >150k/mo patients via Bolt Pharmacy, our main UK brand, and we are profitable. Our strategy leverages two strong theses: the AI doctor that wins will achieve escape velocity using GLP-1s, the fastest growing consumer product in history, and the $2T European healthcare market is overlooked by talented builders. Our master plan involves reaching $100M/yr by end of 2025, $1B ARR by end of 2026, $10B ARR by end of 2028 by blitzscaling Europe and becoming Europe’s largest GLP-1 provider, and $100B/yr by end of 2031 by obtaining regulatory approval for our Full Autonomous Prescribing (FAP) system across Europe and winning large contracts with European payers to mass replace human labor, ultimately becoming the dominant full-stack AI doctor in Europe. By 2035, we aim for $1T/yr, enabling global patient treatment with any medication via AIOS with one line of code and zero human time, becoming the world’s first trillion-dollar healthcare company. We are a young, founder-led company, still in Day 1 with all our work ahead of us.

Requirements

5+ years in expansion, market launch, business operations, general management, or a similarly high-ownership role.
Preference for people who understand & enjoy the scary speed of a high-growth startup.
Personally owned taking European launches from idea to live operations.
Ability to determine which markets are actually worth entering, what must be true for them to work, and whether we should build, partner, or acquire.
Ability to smoothly move from strategy-mode into the trenches, comfortable negotiating partnerships, reviewing contracts, setting up entities, solving supply constraints, and doing whatever else is required to compliantly launch.
Ability to grok complex regulatory environments and work effectively across legal, clinical, and ops.
Ability to learn unfamiliar markets unusually quickly, find the right people, ask sharp questions, separate real blockers from perceived blockers, and reach high-quality decisions without months of research.
Ability to run several country launches concurrently without losing control of the details.
Ability to create clear plans with DRIs and deadlines.
Ability to turn each launch into reusable scaffolding and identify what can be standardised across Europe to continuously reduce the time required to launch.
Operate like a founder, taking responsibility for the result until patients are being served.

Nice To Haves

Experience operating in a heavily regulated industry and knowing how to move quickly without treating compliance as somebody else’s problem.
Experience launching and scaling businesses across multiple European countries, namely Germany, the Netherlands, France, Spain, Italy, and/or the Nordics.
Experience evaluating partnerships, joint ventures, licensing arrangements, or acquisitions as routes into new markets, including conducting diligence, structuring a deal, and closing it.
Using AI to research markets, analyse regulations, evaluate opportunities, draft plans, automate workflows, and increase personal execution capacity.
Experience building and managing a lean, high-performance team across multiple countries.
Having founded something (no matter how small), or joined a project early.
Being one of those timeless people who could be dropped anywhere in the world, in any century, and figure out how to make progress.

Responsibilities

Own European expansion from market research through launch readiness, turning “we should enter this country” into “we can compliantly serve patients here”, then repeat the process faster every time.
Determine which countries we should enter next based on market size, customer demand, unit economics, regulatory complexity and speed to launch.
Identify precisely what is blocking us from launching in each priority country, then construct the plan to plow through blockers.
Choose the fastest compliant route into each market, whether that means architecting internally, partnering with established local providers, and/or acquiring existing infrastructure.
Ensure we have the appropriate legal entities, local/national permissions, registrations, contracts and compliance frameworks required to operate.
Establish the clinical infrastructure required to serve patients, including helping staff the initial clinical team if building from 0.
Secure reliable medication supply, pharmacy partner(s), and fulfilment infrastructure so we can launch quickly and scale without operational constraints.
Coordinate the legal, clinical, product, operational and supply work required for our Growth team to begin testing each market as quickly as possible.
Turn what we learn from each launch into a repeatable system, reducing the time, cost and complexity required to enter the next country.